Lubiprostone, a constipation drug, showed unexpected potential to slow chronic kidney disease in a clinical trial of 150 patients.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
A common constipation drug shows surprising power to protect kidneys
150 Patients patients Clinical trial size
Altered Gut Bacteria Boosting Spermidine n/a Drug mechanism
Moderate Chronic Kidney Disease n/a Condition treated
Preserved Kidney Function n/a Health impact
150 patients in trial
Moderate CKD kidney function preserved